Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 40% ± 23% | |
lung | 15 studies | 27% ± 8% | |
peripheral blood | 15 studies | 29% ± 13% | |
liver | 6 studies | 29% ± 8% | |
intestine | 5 studies | 22% ± 8% | |
heart | 5 studies | 29% ± 6% | |
bone marrow | 4 studies | 24% ± 6% | |
eye | 4 studies | 25% ± 11% | |
lymph node | 4 studies | 31% ± 5% | |
adipose | 4 studies | 46% ± 19% | |
skin | 4 studies | 17% ± 2% | |
placenta | 3 studies | 26% ± 12% | |
uterus | 3 studies | 19% ± 4% | |
kidney | 3 studies | 26% ± 4% | |
breast | 3 studies | 24% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 3089.75 | 2623 / 2642 | 100% | 33.37 | 705 / 705 |
thymus | 100% | 4388.22 | 653 / 653 | 99% | 26.86 | 599 / 605 |
liver | 100% | 2864.26 | 226 / 226 | 98% | 19.16 | 398 / 406 |
lung | 100% | 5378.55 | 578 / 578 | 98% | 27.55 | 1131 / 1155 |
kidney | 99% | 2173.17 | 88 / 89 | 97% | 41.16 | 878 / 901 |
breast | 100% | 6483.24 | 459 / 459 | 96% | 23.40 | 1075 / 1118 |
esophagus | 100% | 4357.53 | 1444 / 1445 | 95% | 24.73 | 173 / 183 |
prostate | 100% | 3702.17 | 245 / 245 | 93% | 17.65 | 467 / 502 |
ovary | 100% | 2865.61 | 180 / 180 | 93% | 14.28 | 399 / 430 |
adrenal gland | 96% | 1684.76 | 247 / 258 | 97% | 20.67 | 223 / 230 |
pancreas | 96% | 1643.25 | 315 / 328 | 97% | 20.51 | 172 / 178 |
uterus | 100% | 3813.01 | 170 / 170 | 93% | 19.54 | 425 / 459 |
skin | 100% | 5419.03 | 1808 / 1809 | 91% | 24.74 | 431 / 472 |
stomach | 100% | 2728.92 | 359 / 359 | 66% | 10.65 | 190 / 286 |
bladder | 100% | 4235.90 | 21 / 21 | 62% | 10.99 | 314 / 504 |
intestine | 100% | 3458.48 | 962 / 966 | 46% | 6.60 | 242 / 527 |
adipose | 100% | 7500.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5703.40 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.71 | 29 / 29 |
spleen | 100% | 3295.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.12 | 45 / 45 |
muscle | 100% | 6426.48 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2640.37 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 5280.53 | 861 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 70% | 8.85 | 56 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043402 | Biological process | glucocorticoid mediated signaling pathway |
GO_0006325 | Biological process | chromatin organization |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0071549 | Biological process | cellular response to dexamethasone stimulus |
GO_0007059 | Biological process | chromosome segregation |
GO_0030518 | Biological process | nuclear receptor-mediated steroid hormone signaling pathway |
GO_0061744 | Biological process | motor behavior |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007165 | Biological process | signal transduction |
GO_0071383 | Biological process | cellular response to steroid hormone stimulus |
GO_0051301 | Biological process | cell division |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0008211 | Biological process | glucocorticoid metabolic process |
GO_0060603 | Biological process | mammary gland duct morphogenesis |
GO_0048708 | Biological process | astrocyte differentiation |
GO_0006111 | Biological process | regulation of gluconeogenesis |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0042921 | Biological process | nuclear receptor-mediated glucocorticoid signaling pathway |
GO_0042711 | Biological process | maternal behavior |
GO_0035249 | Biological process | synaptic transmission, glutamatergic |
GO_0014004 | Biological process | microglia differentiation |
GO_0030325 | Biological process | adrenal gland development |
GO_1902895 | Biological process | positive regulation of miRNA transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0031946 | Biological process | regulation of glucocorticoid biosynthetic process |
GO_0006915 | Biological process | apoptotic process |
GO_0071385 | Biological process | cellular response to glucocorticoid stimulus |
GO_0010467 | Biological process | gene expression |
GO_0150076 | Biological process | neuroinflammatory response |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016020 | Cellular component | membrane |
GO_0016607 | Cellular component | nuclear speck |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005819 | Cellular component | spindle |
GO_0005634 | Cellular component | nucleus |
GO_0017025 | Molecular function | TBP-class protein binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001046 | Molecular function | core promoter sequence-specific DNA binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0004883 | Molecular function | nuclear glucocorticoid receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0034056 | Molecular function | estrogen response element binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005496 | Molecular function | steroid binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_1990239 | Molecular function | steroid hormone binding |
Gene name | NR3C1 |
Protein name | Glucocorticoid receptor (Nuclear receptor subfamily 3 group C member 1) Nuclear receptor subfamily 3 group C member 1 variant hGR-B(54) Nuclear receptor subfamily 3, group C, member 1 (Glucocorticoid receptor) Alternative protein NR3C1 Nuclear receptor subfamily 3 group C member 1 Nuclear receptor subfamily 3 group C member 1 (Nuclear receptor subfamily 3, group C, member 1 (Glucocorticoid receptor)) Nuclear receptor subfamily 3 group C member 1 variant hGR-B(93) Glucocorticoid receptor Nuclear receptor subfamily 3 group C member 1 variant hGR-B(77) Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) |
Synonyms | GCR GRL hCG_37601 GR |
Description | FUNCTION: Receptor for glucocorticoids (GC) . Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors . Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling . Plays a role in rapid mRNA degradation by binding to the 5' UTR of target mRNAs and interacting with PNRC2 in a ligand-dependent manner which recruits the RNA helicase UPF1 and the mRNA-decapping enzyme DCP1A, leading to RNA decay . Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth (By similarity). .; FUNCTION: [Isoform Alpha]: Has transcriptional activation and repression activity . Mediates glucocorticoid-induced apoptosis . Promotes accurate chromosome segregation during mitosis . May act as a tumor suppressor . May play a negative role in adipogenesis through the regulation of lipolytic and antilipogenic gene expression (By similarity). .; FUNCTION: [Isoform Beta]: Acts as a dominant negative inhibitor of isoform Alpha . Has intrinsic transcriptional activity independent of isoform Alpha when both isoforms are coexpressed . Loses this transcription modulator function on its own . Has no hormone-binding activity . May play a role in controlling glucose metabolism by maintaining insulin sensitivity (By similarity). Reduces hepatic gluconeogenesis through down-regulation of PEPCK in an isoform Alpha-dependent manner . Directly regulates STAT1 expression in isoform Alpha-independent manner . .; FUNCTION: [Isoform Alpha-2]: Has lower transcriptional activation activity than isoform Alpha. Exerts a dominant negative effect on isoform Alpha trans-repression mechanism .; FUNCTION: [Isoform GR-P]: Increases activity of isoform Alpha. .; FUNCTION: [Isoform Alpha-B]: More effective than isoform Alpha in transcriptional activation, but not repression activity. .; FUNCTION: [Isoform 10]: Has transcriptional activation activity. .; FUNCTION: [Isoform Alpha-C1]: Has transcriptional activation activity. .; FUNCTION: [Isoform Alpha-C2]: Has transcriptional activation activity. .; FUNCTION: [Isoform Alpha-C3]: Has highest transcriptional activation activity of all isoforms created by alternative initiation . Has transcriptional repression activity . Mediates glucocorticoid-induced apoptosis . .; FUNCTION: [Isoform Alpha-D1]: Has transcriptional activation activity. .; FUNCTION: [Isoform Alpha-D2]: Has transcriptional activation activity. .; FUNCTION: [Isoform Alpha-D3]: Has lowest transcriptional activation activity of all isoforms created by alternative initiation . Has transcriptional repression activity . . |
Accessions | ENST00000504572.5 [P04150-3] E5KQF6 ENST00000502892.5 ENST00000502500.1 ENST00000394466.6 [P04150-3] L8E9L6 ENST00000343796.6 [P04150-1] H6V744 Q3MSN1 A0A5B9RIM3 ENST00000508760.5 F5ATB8 A0A494C0P1 ENST00000652686.1 ENST00000424646.6 [P04150-10] B6ZGU6 D6RDA9 E5KQF5 F1D8N4 ENST00000394464.7 [P04150-1] Q3MSN4 H6V745 ENST00000415690.6 [P04150-2] P04150 A0A411AGW6 A0A411AGV9 A0A411AGV5 ENST00000503201.1 [P04150-1] ENST00000514699.1 ENST00000231509.7 [P04150-3] ENST00000510170.5 |